4-(phenylthio)butanoic acid has been researched along with Cirrhosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chiba, T; de Caestecker, MP; Hukriede, NA; McDermott, L; Novitskaya, T; Paueksakon, P; Zhang, KX | 1 |
| Calcutt, MW; Chiba, T; de Caestecker, MP; Goldberg, ND; Hukriede, NA; Huryn, DM; McDermott, L; Novitskaya, T; Patel, K; Sanker, S; Skrypnyk, NI; Skvarca, LB; Vernetti, LA; Vinson, PN; Vogt, A; Woods, C | 1 |
2 other study(ies) available for 4-(phenylthio)butanoic acid and Cirrhosis
| Article | Year |
|---|---|
A PTBA small molecule enhances recovery and reduces postinjury fibrosis after aristolochic acid-induced kidney injury.
Topics: Acute Kidney Injury; Animals; Aristolochic Acids; Butyrates; Disease Models, Animal; Fibrosis; Histone Deacetylase Inhibitors; Kidney Tubules; Mice; Mice, Biozzi; Reperfusion Injury; Sulfides | 2014 |
Delayed treatment with PTBA analogs reduces postinjury renal fibrosis after kidney injury.
Topics: Acute Kidney Injury; Animals; Butyrates; Cell Proliferation; Cell Survival; Disease Models, Animal; Fibrosis; Kidney; Male; Mice; Sulfides; Zebrafish | 2016 |